A new Perspective published in The New England Journal of Medicine led by researchers from the Harvard Pilgrim Health Care Institute calls for urgent regulatory reforms to address the rising trend of physician strikes in the United States.
AstraZeneca, Daiichi Sankyo still need key overall survival results on TROP2 ADC in breast, lung cancer: #ESMO23
MADRID — Headed into the year’s second-largest cancer conference, expectations were a little subdued for AstraZeneca’s next big bet on antibody-drug conjugates. The pharma’s Daiichi
October 24, 2023